ARISTA SM0007-USARecalls & reported problems
Davol Inc. · Arista AH Absorbable Hemostatic Particles, 5g bellows container · Class 3 · Implant
All models of ARISTA (6)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 5
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00801741044144), received between Jun 13, 2017 and Feb 10, 2023 — classified as 5 injuries.
The most frequently reported specific device problem is “Patient-Device Incompatibility” (4 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Patient-Device Incompatibility4
- Insufficient Device Problem Information1
Patient problems
- Abscess3
- Erythema1
- Low Blood Pressure/ Hypotension1
- Pain1
- Pulmonary Edema1
- Purulent Discharge1
- Renal Failure1
- Swelling/ Edema1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
InjuryFeb 10, 2023Patient-Device Incompatibility; Patient-Device Incompatibility
AS REPORTED, APPROXIMATELY 3 G OF THE 5 G ARISTA AH WAS USED DURING A THYROIDECTOMY PROCEDURE ON (B)(6) 2023. THE SURGEON STATED THE RESIDUAL ARISTA AH MATERIAL WAS NOT REMOVED BY IRRIGATION OR ANY OTHER METHODS. AS REPORTED, THE PATIENT DEVELOPED PURULENCE LESS THAN 24 HOURS POST OP; THEREBY THE PATIENT WAS TAKEN BACK TO THE OR ON (B)(6) 2023 FOR NECK SWELLING, REDNESS, PAIN AND EVACUATION OF PURULENCE WAS PERFORMED. IT WAS ALSO REPORTED THAT THE PATIENT WAS STARTED ON PROPHYLACTIC ANTIBIOTICS AND THE CULTURES WERE STERILE.
Patient problems: Erythema; Pain; Purulent Discharge; Swelling/ Edema
MAUDE report 16345551 ↗InjuryDec 14, 2022Patient-Device Incompatibility; Patient-Device Incompatibility
AS REPORTED, DURING AN UNKNOWN PROCEDURE, ARITA AH WAS USED ON THE VAGINAL CUFF AND RESIDUAL MATERIAL WAS NOT REMOVED AFTER HEMOSTASIS WAS ACHIEVED. AS REPORTED, THE PATIENT DEVELOPED WITH VAGINAL CUFF ABSCESS. IT WAS ALSO REPORTED THAT PATIENT IS PRESENTED TO THE EMERGENCY DEPARTMENT VISITS ON SEVERAL OCCASIONS AND THE PATIENT IS DOING WELL AT THIS TIME.
Patient problems: Abscess
MAUDE report 15982980 ↗InjuryDec 14, 2022Patient-Device Incompatibility; Patient-Device Incompatibility
AS REPORTED, DURING A PROCEDURE, ARITA AH WAS USED ON THE VAGINAL CUFF AND RESIDUAL MATERIAL WAS NOT REMOVED AFTER HEMOSTASIS WAS ACHIEVED. AS REPORTED, THE PATIENT DEVELOPED WITH VAGINAL CUFF ABSCESS. IT WAS ALSO REPORTED THAT PATIENT UNDERWENT 2 SUBSEQUENT SURGERIES, AND THE PATIENT IS DOING WELL AT THIS TIME.
Patient problems: Abscess
MAUDE report 15982625 ↗InjuryDec 14, 2022Patient-Device Incompatibility; Patient-Device Incompatibility
AS REPORTED, DURING AN UNKNOWN PROCEDURE, ARITA AH WAS USED ON THE VAGINAL CUFF AND RESIDUAL MATERIAL WAS NOT REMOVED AFTER HEMOSTASIS WAS ACHIEVED. AS REPORTED, THE PATIENT DEVELOPED WITH VAGINAL CUFF ABSCESS. IT WAS ALSO REPORTED THAT PATIENT IS PRESENTED TO THE EMERGENCY DEPARTMENT VISITS ON SEVERAL OCCASIONS AND THE PATIENT IS DOING WELL AT THIS TIME.
Patient problems: Abscess
MAUDE report 15982577 ↗InjuryJun 13, 2017Insufficient Device Problem Information; Insufficient Device Problem Information
IT WAS REPORTED THAT DURING A GYNECOLOGICAL PROCEDURE TO REMOVE CYSTS FIBROIDS AND ADHESIONS, BARD ARISTA AH WAS USED IN CONJUNCTION WITH AN AUTO TRANSFUSION DEVICE. THE CASE WAS COMPLETED AND THE PATIENT WAS TAKEN TO RECOVERY IN WHICH AFTER ABOUT 15 MINUTES BEGAN TO EXHIBIT INCREASED HEART RATE, HYPOTENSION, LOW URINE OUTPUT AND PULMONARY EDEMA. THE PATIENT WAS TAKEN TO ICU WHERE SHE WAS STABILIZED AND CONTINUES TO BE ON ASSISTED VENTILATION. THE SURGEON HAS REQUESTED A DOCTOR TO DOCTOR CONSULT.
Patient problems: Low Blood Pressure/ Hypotension; Pulmonary Edema; Renal Failure
MAUDE report 6637382 ↗
Other Agent, absorbable hemostatic, non-collagen based devices
- ETHICON 3013SPEthicon, LLC · Agent, absorbable hemostatic, non-collagen based3 deaths392 reports
- SURGICEL FIBRILLAR 1961Ethicon Sàrl · Agent, absorbable hemostatic, non-collagen based1 recall2 deaths120 reports
- SURGICEL FIBRILLAR 1963Ethicon Sàrl · Agent, absorbable hemostatic, non-collagen based1 recall44 reports
- SURGICEL 1953Ethicon Sàrl · Agent, absorbable hemostatic, non-collagen based56 reports
- SURGICEL 1952Ethicon Sàrl · Agent, absorbable hemostatic, non-collagen based1 death41 reports
- SURGICEL FIBRILLAR 1962Ethicon Sàrl · Agent, absorbable hemostatic, non-collagen based35 reports
- Veriset HP0510ECovidien LP · Agent, Absorbable Hemostatic, Non-Collagen Based1 death33 reports
- SURGICEL SNoW 2082Ethicon, LLC · Agent, absorbable hemostatic, non-collagen based24 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page